Aug 14, 2020
Izabela Podgorski, Ph.D., researcher at Karmanos Cancer Institute receives RO1 grant to continue research on metastatic prostate cancer
Aug 12, 2020
Margaret Brennan to Keynote American Urological Association's Annual Urology Advocacy Summit
Aug 12, 2020
Potential Enhancement of Prostate Cancer Treatment Options: First Patient Randomized in Phase III Trial
Jun 22, 2020
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
Jun 18, 2020
Wider Range of Prospective Patients in the UK, Canada and the US for Continued Clinical Study
Jun 17, 2020
Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting
Jun 16, 2020
Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients
Jun 16, 2020
HALO Diagnostics Interim Data from Clinical Trial Shows Groundbreaking Results for New Prostate Cancer Treatment
Jun 16, 2020
A Future Alternative to Hormonal Treatment for Prostate Cancer
Jun 15, 2020
Global Prostate Cancer Market Analysis to 2028 - Prostate Cancer Market Expected to Increase Despite Generic Abiraterone Entry
Jun 12, 2020
QBioMed to Support and Exhibit at Living Beyond Breast Cancer 2020 Virtual Conference on June 13-14, 2020
Jun 11, 2020
Recent Research And New Multidisciplinary Framework For Genetic Testing In Prostate Cancer Supports Broader Use Of Panels, Testing In Early Stage Disease
Jun 11, 2020
Bio-Techne And ZERO - The End Of Prostate Cancer Announce Partnership To Fund Education And Awareness Campaigns To Empower Men With Prostate Cancer
Jun 09, 2020
CorTechs Labs and HealthLytix Announce Merger to Expand Leadership in Radiology AI Applications to Detect and Quantify Certain Cancers and Neurodegenerative Disease
Jun 04, 2020
Cancer Diagnostics Global Market Estimated to Reach $10,627.4 Million by 2026
Jun 03, 2020
Zeulide Depot(TM) is now Covered by the Ontario Drug Benefit (ODB) Program for Patients Living with Prostate Cancer
May 29, 2020
XTANDI® (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
May 29, 2020
Sumitovant Biopharma Announces Myovant Sciences' Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine
May 29, 2020
Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer
May 27, 2020
ESSA Pharma to Present at Jefferies Virtual Healthcare Conference